Brought to you by 
Merck KGAA grosses €1bn through capital increase
06 Feb 2007
Executive Summary
Majority shareholder E. Merck OHG and other existing investors purchased 13.3mm new shares of Merck KGAA for €78 ($101) per share (an 11% discount), providing proceeds of €1.03bn to the company. The capital increase was pursued in part to finance Merck's recent acquisition of Serono.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Other
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Merck KGAA grosses €1bn through capital increase
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice